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ABSTRACT 
 
With cancer being a wide spread threat to humanity, plants have an important role in cancer 
prevention and in therapy. Medicinal plants provide new active chemo-preventive molecules. It is 
suspected that Ocimum sanctum would be a potent weapon discovered so far in fighting against all kinds 
of Cancer. There are many HDAC inhibtiors, but they are toxic in nature, this study aim at finding a 
phytochemical which is less toxic to human. For this ethanolic and methanolic extract of Tulsi leaves and 
inflorescence were detected to check whether they contain any components that can inactivate HDAC and 
can activate tumor suppressor genes. Further the anti- proliferative and anti-apoptoic effect of ethanolic 
and methanolic extract is studied. The role of theses extracts on the expression of tumor suppressor gene 
(Maspin), transcriptional factor (Snail), and epigenetic modulator (HDAC1, HDAC2) is investigated along 
with their anti-migratory effects on cancer cells. It is very much clear from the current investigation that 
the tulsi leaf and inflorescence extracts have the anti-cancer potential. This anti-cancer potential is due to 
the combinatorial effect of anti-proliferative, apoptotic and anti-migratory effect of the tulsi extracts. It is 
demonstrated from our experiments that the EETL exert more anti-cancer effect on breast cancer cells 
than METL and EETI. This investigation also demonstrates the higher efficacy of EENL in restoring the 
expression of maspin with concurrent enhancement of HDAC-1 and HDAC-2 mRNA levels, and reduced 
expression of snail. This reflects the HDAC inhibitory activity of tulsi extract. 
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1. INTRODUCTION 
Medicinal plants have been in playing a vital role throughout human history. Plants 
have a number of chemically synthesised compounds that are used in many biological 
functions. About 12,000 such compounds have been isolated so far which constitute only 
10% of the total chemical compounds in plants (Gupta et al., 2005). These chemical 
compounds mediate their effect on human body through processes identical to those 
conventional drugs in terms of how they work. Since time immortal, plants are used for 
maintaining health and also for curing many diseases. About 120 active compounds have 
been isolated from plants, which are being used as herbal medicine today. About 80% 
similarity is seen between their traditional use and modern therapeutic use. About two third 
of the total plant species in the world are estimated to have medicinal values. In modern era at 
least 7,000 medical compounds have been derived from plants. India is rich in medicinal 
herbs and spices consisting of about 2000 species.  Traditional medicines such as Ayurveda, 
Unani, Siddha are studied for their chemical and pharmacological potential medicinal 
value[1] (Sandhu and Heinrich, 2005). Since thousand years human beings have been using 
medicinal plants for treating different diseases. Traditional medicines are still preferred by 
many people who can’t afford pharmaceutical products for their physical and psychological 
requirements. In many of the developing countries mostly in rural areas people rely on 
traditional medicines for their primary health care. These are comparatively cheaper and safer 
than the modern synthetic medicines (Ammara et al, 2009) 
With cancer being a wide spread threat to humanity, plants have an important role in 
cancer prevention and in therapy. Medicinal plants provide new active chemo-preventive 
molecules. A number of mechanisms are responsible for the derivation of plant compounds 
that have anti-tumor activities; these mechanisms involve effects on cytoskeletal proteins 
which play a key role in cell division, DNA topoisomerase enzymes inhibition, anti-protease 
or anti- oxidant activity, stimulation of the immune system etc. Plants can delay or prevent 
cancer on set and also can support the immune system, thereby improving body resistance to 
Cancer. Breast Cancer has been proved to be the fatal breed of cancers among female. It is 
the cancer originating from the tissues of breast, particularly from intramural lining of milk 
ducts  which impart the ducts with milk. Cancers emanating from ducts are said to be ductal 
carcinomas, whereas cancers beginning from lobules are called as lobular carcinomas. The 
exposition of breast cancer is 22.9% among cancers in women.  Breast cancer caused about 
4,58,503 deaths worldwide which is at least 13.7% of deaths in women due to cancer. The 
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third most cancer after lung and stomach cancer is breast cancer. In US breast cancer 
accounts for one-third of all cancer incidents. It has become the second cause of death among 
cancer next to lung cancer. The American cancer society had estimated 1,82,000 new cases in 
1993 in US and 46,000 deaths in women were due to cancer. In the past two and three 
decades long term increase in breast cancer have been observed similar to that occurs in US ( 
Lipworth L,1994). A significant decrease in breast cancer is seen due to anti-cancer 
therapeutics  
In the present day, 1.3 million women are detected with breast cancer each year. 
During the last 25 years, incidences related to breast cancer have risen to a greater number. 
Moreover, deaths because of breast cancer have also been declining constantly since 1990 
due to earlier detection and advanced treatments. Breast cancer rate is relatively low in India, 
despite of its huge population size. In India, generally breast cancer is not detected earlier, in 
comparison with developing or developed country. Therefore breast cancer death rate is high 
in India. 
1.1 Pharmacological importance of plants in cancer  
In recent years, engrossment in cancer treatment by plants and their phytochemicals 
has been increased. Though different plant parts have prospects for curative use and 
chemoprevention, their mechanisms is very difficult to understand. Therefore extensive 
research has been recognised for many targeted molecules which can have potential to be 
used as an anti-cancer agent. There are instances of modifying abilities of many plants and 
plant products on many signalling pathways, along with their anti-inflammation and anti-
apoptotic target for cancer therapy. There are several phytochemicals like resveratrol , allicin 
, lycopene, indole-3-carbinol , vitamin C , -gingerol , emodin , natural antioxidant mixture , 
sulphoraphan, ellagic acid , myrecitin, vanillin and eugenol that have anti-cancer property. 
They act through one or more signaling pathways.( AR Khuda-Bukhsh et al,2014) 
1.2. Ocimum sanctum in Cancer treatment 
One of such medicinal plant having the above character is Ocimum sanctum which is 
used traditionally as medicine in south-east Asia. It possesses anti-inflammatory, analgesic, 
antipyretic, antidiabetic, hepatoprotein, hypolipidemic, immune modulatory and anti-stress 
activity. It has been seen that Ocimum sanctum and some of its phytochemicals such as 
eugenol, linoleic acid, luteolin, β-sitosterol that prevents skin, liver, oral and lung cancers. 
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Their effects are mediated by increasing the anti-oxidant activity, inducing apoptosis, altering 
the gene expression, and inhibiting metastasis (Baliga et al). 
Long ago some researchers tried to put some Ocimum sanctum leaves over tumour 
cells which resulted in the inhibition of the growth of tumour cells. From then, Ocimum 
sanctum has been suspected as a medicine to cure Cancer. Ocimum sanctum has abundant 
quantities of Eugenol, the anti-cancerous component. It is suspected that Ocimum sanctum 
would be a potent weapon discovered so far in fighting against all kinds of Cancer. Now 
scientists are trying to find new ways in which Eugenol can be produced in larger amount. If 
this succeeds, Ocimum sanctum will be officially declared as anti-Cancer medicine and can 
be used in curing Cancer. Many researches are going on to genetically modify Ocimum 
sanctum so as to obtain more anti-Cancerous compound. No reports have been found on the 
effects of Ocimum sanctum on Breast Cancer till now. (Makker et al, 2007) 
The properties of Ocimum sanctum is because of the active components present in the 
plant, which includes eugenol, linoleic acid, oleic acid, rosmarinic acid, Ocimarin, isorientin, 
orientin, aesculectin, aesculin, chlorgrnic acid, galuteolin, gallic acid, Citronellal, Camphene, 
Sabinene, Dimethyl benzene , Ethyl benzene, Vitamin C, Calcium, and many more. 
Molecular structures of some of the components of Ocimum sanctum are as follows. ( J Baby 
et al, 2013) 
 
Figure 1: Molecular structures of some of the active components of Ocimum sanctum  
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1.3. Epigenetics and Cancer 
Epigenetic is all about alterations in the accessibility of chromatin in trancscriptional 
regulation either by locally or globally via DNA modifications or in nucleosome 
rearrangement. Epigenetic is an important event in the development of mammals including 
the maintenance of tissues and their function. Epigenetic gene expression mainly involves the 
nucleosome present on the middle. It is made up of two turns of DNA wrapped around a 
histone octamer which consists of two subunits of H2A, H2B,H3 and H4. H1 is the linker 
histone that attaches and helps in the further compaction of histones. Besides core histones 
there are a variety of histone proteins that can be inserted within the nucleosome probably 
serving like landmarks for different cellular functions. Histone proteins have a N-terminal tail 
that protrude out of the nucleosomal core particle. The epigenetic signals bind on these tails 
which serve as a regulatory register. The covalent modifications of hictones include 
acetylation, methylation, phosphorylation, ubiquitination, ADP-ribosylation and sumoylation. 
Acetylation is related to the activation of gene expression which is due to the balance 
between acetylation and deacetylation. Besides histones, transcriptional regulators, many 
chromatin modifiers including intracellular signal transducers and post translational 
modifications by acetylation. HAT and HDAC are mutated and silenced in many cancers. 
HDACs have opposite function in cancer development. HDAC play a vital role in gene 
silencing of tumor suppressor genes and also in their mechanism. HDACs are linked with 
many types of silencing mechanism such as histone methylation, DNA methylation, PcG 
mediated repression etc. Moreover HDAC activity is important in the preparation of 
templates for histone methyl transferases by the removal of the acetyl group and there by 
obstructing methylation (Lund and Lohuizen, 2014). 
 
.  
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Figure 2: Schematic representation of (A) a nucleosome and (B) transcriptional activation 
and repression in chromatin (Adapted from Stumpp et al, 2005) 
1.4. Role of histone deacetylases (HDACs) in cancer  
Besides the modern development of better and productive anticancer drugs, resistance 
to some kind of chemicals has become a considerable cause for failure of treatments. Many 
evidences are there that proves that epigenetic has a vital role in developing resistance. 
HDACs have a key role in activation of gene expression. They are linked with different types 
of cancers and thus enhance cancer development. (Hrabeta J et al, 2013). The equilibrium 
between histone acetylation and histone deacetylation is an epigenetic level with an important 
role in the gene expression. Histone acetyltransferase (HAT) induces histone acetylation 
which is associated with transcription, whereas histone deacetylase induces hypoacetylation 
associated with gene silencing. Since both HAT and HDAC induces aberrant expression of 
genes, they regulate different functions such as apoptosis, cell proliferation etc. Thus HDACs 
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are one of the important therapeutic for treatment of cancer. Histone acetylation is also linked 
with chromatin remodelling along with gene transcription. During acetylation the negatively 
charged acetyl groups are bound to the positively charged lysine residues, as a result DNA is 
loosely bound to histones and a euchromatin structure is formed. This helps the transcription 
factors to bind to the DNA and thus transcription occurs. This is how HAT helps in the 
activation of gene expression. But in case of deacetylation catalysed by HDAC the acetyl 
groups are removed as a result of which the DNA and the histones which have a strong force 
of attraction form a heterochromatin structure. Therefore the transcriptional factors can’t bind 
to the DNA and hence no transcription occurs. Thus HDAC helps in the gene silencing. 
Histone acetylation is associated with DNA repair, recombination and chromatin assembly. 
HDAC also regulates many cell processes like cell cycle progression, apoptosis etc. HDACs 
are recruited independently to DNA without DNA methylation. This is the result of the 
involvement of transcription factors and nuclear receptors. Basically HDAC1 and HDAC2 
are involved in the gene silencing regulated by Rb, retinoblastoma protein. Deactivation of 
DNA methylation and histone acetylation has a fatal consequence of inactivation of gene 
expression. Hypomethylation is associated with the loss of acetylated lys 16 and 
trimethylated lys20in human cancer (Ropero S et al, 2007). 
1.5.  Role of maspin in cancer 
Mammary serine protease inhibitor (Maspin) is one of the members of the serpin 
superfamily, whose expression is down-regulated prostate cancers as wel as in braest cancer 
but over-expressed in colo-rectal cancers which shows that maspin has activities depends on 
cell types. Cancer in breast and ovary has a maspin importance associated with its 
localization: maspin expression in nucleus indicates a good projection, whereas cancer in 
panceas predicts a poor one. An increase in the adhesion due to the maspin can lead to the 
inhibition of tumour metastasis, because tumor metastasis generally requires the invasion and 
detachment of tumor cells by the basement membrane. Moreover different location of maspin 
inside the cell or its epigenetic changes may explain the dissimilar behavior in the expression 
of maspin between tumors.( Berardi et al,2013).Structural considerations shows that maspin 
can act as a serine protein inhibitor to interact with serine protease like that of HDAC1. E-
acetyl lysine is hydrolysed residues in its substrate proteins by the activity of HDAC1, which 
is the function of the catalytic domain resembling to metallo proteinases. Maspin is expressed 
in a manner that can act as the regulator of HDACs (Li X et al, 2013).  
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Maspin expressions in cancer cells are controlled by the methylation in CpG islands. 
However in Breast Cancer hypermethylation of CpG islands in Maspin promoter is linked 
with inactivation of transcription. Breast cancer cells have both Hypermethylation and 
deacetylation of histone that have shown to repress expression of maspin. (Dokras A et al, 
2006) 
1.6.   SNAIL 
The Snail is a superfamily of zinc-finger transcription factors. It is associated in 
cellular processes that indicate distinct cell movements, both in the embryonic development 
process and during the accession of invasive properties during progression of tumour. There 
are many different family members of snail superfamily who have also been compromised in 
the signalling cascade that are conferred with left–right identity, including  the genration of 
appendages, cell division,cell survival, neural differentiation etc. One among the best-known 
functions of snail family is to induce epithelial to mesenchymal transitions (EMTs), which 
then convert epithelial cells directly into migratory mesenchymal cells. (Nieto et al, 2002) 
Snail is recognised as a component of pathways during early development of flies and 
mammals including metastasis. They basically act to suppress gens which encode important 
structural elements of cell-cell junction apparatus, like that of E-cadherin and ocdudin which 
results in a de-differentiated mesenchymal phenotypic characterization by increasing motility 
rate (Sugimach K et al, 2003). 
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2. REVIEW OF LITERATURE 
It has been found that the antitumor mechanism of ethanolic extract of Tulsi is 
elucidated in A549 cells and also in Lewis lung carcinoma (LLC) animal model. It is seen 
that ethanolic extract of Tulsi exerts cytotoxicity against A549 cells, exhibits apoptotic bodies 
in A549 cells and increases the sub-G1 population. Furthermore Tulsi ethanolic extracts also 
cleaves poly Adenophosphate (ADP)-ribose polymerase (PARP), and release cytochrome C 
to the cytosol and activate caspase-9 and caspase-3 proteins. Ethanolic extract of Tulsi 
increases the ratio of apoptotic proteins like Bax protein with Bcl-2 and inhibits the 
phosphorylation of Akt and extracellular signal regulated kinase (ERK) in A549 cancer cells. 
In addition it was found that ethanolic extract of Tulsi can suppress the growth of LLC 
inoculated onto C57BL/6 mice in a dose- dependent manner. Overall, these results 
demonstrate that ethanolic extract of Tulsi induces apoptosis in A549 cells via a mitochondria 
caspase dependent pathway and also inhibits the in vivo growth of LLC, suggesting that 
ethanolic extract can be applied to lung carcinoma as a chemopreventive candidate.( V 
Magesh et al,2009)  
Moreover, the anticancer property of tulsi leaves extract was verified, using Benzo 
pyrene induced fore-stomach and 7,12 dimethyl benzanthracene initiated skin 
papillomagenesis. The activities like hepatic glutathione S-transferase and DT-diaphorase 
were found to be increased above basal level by tulsi leaves (Anti-cancer effect was verified 
from decreased tumor, also from the lesser number of animals with tumors).  Moreover, Tulsi 
leaves extract was seen to be highly efficient in inhibiting carcinogen-induced tumor 
instances in both the tumor models. 
The anticancer property of Tulsi was studied in skin papillomagenesis using Benzo-
pyrene-induced fore-stomach and 7,12 dimethyl benzanthracene (DMBA). Chemopreventive 
response of Tulsi was detected was confirmed from the lowering tumor , also from the 
reduction in the number of tumour bearing animals. Morever Tulsi leaves extract was much 
effcient in the reduction of carcinogen induced tumor instances in both the models. Tulsi 
leaves can be used as a potential anti-cancer agent because of its efficiency in the induction of 
drug detoxifying enzyme such as DST and DTD and also by checking carcinogenic phase I 
enzyme. Since tulsi has shown anti- toxic effect at all the tested doses, it may be applied in 
chemoprevention of cancer, in order to decrease the risk of cancer.(Dasgupta et al,2004) 
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Tulsi has been explored for its anti-cancer activity for 7,12-dimethylbenz-anthracene 
(DMBA)-induced buccal pouch carcinogenesis. Fresh leaf paste of Tulsi and its aqueous 
extract along with the ethanolic extract were either applied locally or orally administered to 
buccal pouch mucosa of animalsand they were allowed to be exposed to 0.5% of DMBA. It 
was observed that carcinomas of papillomas and squamous cell were significantly reduced, 
along with rise in the survival rate in the topically applied area and orally administered 
extracts to the animals. The orally administered aqueous extract was found to be more 
effective among other two forms. These findings were confirmed by the histological 
observations carried out on the mucosa. Further studies of fluorescent spectral at 405 nm 
excitation on the mucosa of control, DMBA and that of the extracts orally administered 
experimented animals were found to show prominent maxima at 430 nm for control, 628 nm 
for DMBA induced carcinomas. Furthermore the aqueous and ethanolic leaves extracts 
administered animals were found to show at 486 nm and 488 nm, respectively. The 
fluorescent absorbance at 630 nm was significantly reduced and the ratio of fluorescent 
intensities at 520 nm and 630 nm were significantly increased in orally administered extracts 
compared to DMBA treated animals. These observations suggest that the orally administered 
extract of Tulsi can have the ability to prevent the early events of cancer (Karthikeyan K et 
al,1999). 
There are reports about the modulating effect of ethanolic leaves extract of Tulsi on 
the activities of aryl hydrocarbon hydroxylase enzymes and also in the cytochrome p‐450, 
and in the liver and glutathione‐S‐transferase. Tulsi extract has also influence in reducing 
glutathione level in the lung, liver and stomach of the mouse. Oral treatment with the leaf 
extract at an amount of 400 and 800 mg/kg body wt for 15 days would significantly increase 
the activities of cytochrome p‐450, aryl hydrocarbon hydroxylase, and glutathione 
S‐transferase. All of these are important in the detoxification of carcinogens and mutagens. 
The leaf extract also elevated the reduced glutathione level in stomach tissues (p < 0.01, p < 
0.001), liver and lung. Mice when fed with a diet that contain 0.75% butylated 
hydroxyanisole that revealed no change in the hepatic cytochrome p‐450 and aryl 
hydrocarbon level, but alterations were observed in case of hepatic cytochrome b5 and also in 
glutathione S‐transferase activity in hepatic and extrahepatic organs in a time‐responsive 
manner. The observations suggest further exploitation of Tulsi leaf extract or its active 
principle involved in the chemoprevention of carcinogenesis in different animal model 
systems.( Banerjee S et al,2009) 
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  The anti-metastatic activity of ethanolic extract of Tulsi leaves were 
investigated through activation of anti-oxidative enzymes. Ethanolic Extract of Tulsi Leaves 
exerts cytotoxicity against Lewis lung carcinoma (LLC) cells. Also, Ethanolic Extract of 
Tulsi Leaves significantly inhibits cell adhesion and invasion as well as activities of matrix 
metalloproteinase-9 (MMP-9). But it has no effect on MMP-2, which indicates the important 
role of MMP-9 in anti-metastatic regulation of Ethanolic Extarct of Tulsi Leaves. In addition, 
Ethanolic Extract of Tulsi Leaves significantly reduces the tumor nodule formation and lung 
weight in LLC-injected mice. Hematoxylin and eosin (H&E) staining confirms the inhibitory 
effect of EETL on metastasis. Notably, it was also found that Ethanolic Extarct of Tulsi 
Leaves enhances the activities of anti-oxidative enzymes in a concentration-dependent 
manner. This study supports that Ethanolic Extract of Tulsi Leaves can be a potent anti-
metastatic candidate through inactivation of MMP-9 and enhancement of anti-oxidant 
enzymes ( Kim Sun-Chae et al, 2010). 
A study was done to determine the efficiency of flavonoid vicenin-2 (VCN-2), which 
is an active constituent present in the medicinal herb Tulsi. It was taken in combination with 
docetaxel (DTL) in carcinoma of prostate (CaP). It was observed that VCN-2 is able to 
effectively induce anti-proliferative, pro-apoptotic and anti-angiogenic effect in CaP cells 
(PC-3, DU-145 and LNCaP) irrespective of their androgen responsiveness or p53 status. 
VCN-2 inhibited EGFR/Akt pathway. Morever it also decreased c-Myc, cyclin B1, CDK4, 
PCNA and hTERT in vitro. VCN-2 was seen to reach a level of 2.6 ± 0.3 μmol/l in serum 
after oral administration in mice. This reflected that VCN-2 is orally absorbed. The i. v. 
administration of docetaxel (DTL), which is the current drug of choice in androgen-
independent CaP, is found to be associated with dose-limiting toxicities like febrile 
neutropenia. This has led to characterization of different routes of administration and 
potential combinatorial regimens. In this regard, DTL in combination with VCN-2 
synergistically inhibited the growth of prostate tumors in vivo with a greater decrease in the 
levels of AR, , pAkt, PCNA, cyclin D1, Ki67, CD31, and increase in E-cadherin. VCN-2 has 
been investigated for radioprotection and anti-inflammatory properties. This is the first study 
on the anti-cancer effects of VCN-2. In conclusion, these investigations collectively provide 
strong evidence that VCN-2 is effective against CaP progression along with indicating that 
VCN-2 and DTL co-administration is more effective than either of the single agents in 
androgen-independent prostate cancer.(Nagaprashanthaa L D et al,2011) 
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In an experiment aqueous extracts of mature Tulsi leaves were prepared related 
Processes related to tumour progression and angiogenesis like that of proliferation, apoptosis, 
chemotaxis 3D growth tumor growth were studied in the presence or absence of the tulsi 
leaves extract. In another experiments a comparative study was made with purified 
commercially available active components of Tulsi such as eugenol and ursolic acid. 
Aqueous Tulsi leaf extract was found to inhibit cell proliferation, anchorage independent 
growth of cells, migration, 3D growth and morphogenesis including the induction of COX-2 
in breast cancer cells. A comparative study with eugenol, and ursolic acid found to show that 
the inhibitory effects on chemotaxis and 3D morphogenesis of breast cancer cells were 
confined to Tulsi extract. Morever, Tulsi extracts reduced tumor size and neo angiogenesis in 
a MCF10 DCIS.com xenograft model of human DCIS. This experiment shows that tulsi leaf 
extract might be effective as a breast cancer prevention and therapeutic agent and can be 
considered as additive in the arsenal of components aimed at combating breast cancer 
progression and metastasis. 
In a study, eugenol the active component of Tulsi derived from Eugenol caryophyllata  
is found to inhibit gene expression activity of inducible cyclooxygenase (COX-2) in 
lipopolysacharide (LPS) activated mouse macrophage cells. Ten COX-2 is found to catalyze 
the conversion of arachidonic acid to prostaglandins11. This is the early response of gene 
when it is stimulated by serum, mitogens,cytokines and hormones. There were twelve Studies 
which have shown that selective COX-2 inhibitors help in the reduction of the human breast 
cancer. It is demonstrated by the inhibition of COX-1 and COX-2 levels by eugenol and six 
other similar phenolic compounds extracted from Tulsi leaves and stems. Ursolic acid 
another compound isolated from Tulsi has been shown to suppress nuclear factor-κB (NF-
κB), which helps in the regulation of the expression of many genes whose products are 
involved in carcinogenesis. Thus, agents that are responsible to suppress COX-2, NF-κB 
activation have the potential to suppress tumorigenesis and have therapeutic effect.( Makker 
et al,2007) 
While maspin occurs in normal breast tissue and normal breast cells in culture, it is 
not present in breast cancer tissue and breast cancer cells in culture. An experiment suggested 
a biologically relevant explanation about the inhibition mechanism of recombinant Maspin 
(rMaspin) in human breast cancer cell line MDA-MB-435 from invading in vitro. Addition of 
rMaspin to those cells resulted in a decrease in the in vitro invasiveness with an increase in 
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their cell surface expression of the α5-containing integrin, and an increase in their adherence 
to fibronectin. These results were confirmed by Northern blot analysis, which showed an 
increase in mRNA in rMaspin treated cell also by the observations of 1)  treated cells 
showing inhibition of increased adhesion  to fibronectin, and 2) facilitating their ability to 
invade through the fibronectin matrix in vitro at a rate equal to the untreated controlled cells. 
These observations supported previous observations that there is a competitive reversion of 
rMaspin action in breast cancer cells that were treated with an RGD peptide known to block 
integrin function. Together, these results indicated a functional change in response of MDA-
MB-435 cells to their surrounding which could have been induced by rMaspin and includes 
both transcriptional and translational processes in the cells. A relevant observation from this 
study is invasive and metastatic cells appearance to assume a more benign, epithelial-like 
morphology in response to rMaspin. Whereas E-cadherin expression did not appear to 
increase with respect to rMaspin, this indicates that the actual junctional adhesion complexes 
had not been formed during the 24 hour period of these observations. Although rMaspin 
treatment also cause a decrease in the cell surface expression of the α2- and β1-containing 
integrins, a change was absent in the ability of the cells to adhere to any of the ligands that 
are associated with these integrins. Furthermore, the inability to block antibody to the α6-
subunit to restore the invasiveness of the rMaspin treated cells through the laminin/gelatin 
matrix barrier in the in vitro invasion assay suggests that there is a specific relationship 
between the α5-containing integrin and rMaspin which apparently does not exist with the 
other integrins. 
In brief these observations indicated that rMaspin reduced the invasive potential of 
MDA-MB-435 cells by altering their integrin profile which changes how they recognize and 
interact with their extracellular environment. rMaspin treated cells shows more adhesion to 
fibronectin-containing biological substrates and are subjected to phenotypic changes that 
resulted in the conversion from an invasive, fibroblastic phenotype to an epithelial-like, less 
invasive phenotype.( Richard E.B,) 
In an experiment it is proved that aberration in cytosine methylation and chromatin 
condensation of the maspin promoter usually participates in the maspin suppression during 
neoplastic progression. For testing this, the cultured normal human mammary epithelial cells 
(HMECs) were compared to 9 cultured human breast cancer cell lines. It was observed that 
HMECs expressed maspin mRNA and displayed a non-methylated maspin gene promoter 
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with an euchromatin. It was seen that maspin expression was absent in seven out of nine 
breast cancer cell lines and six of these seven maspin-negative breast cancer cell lines 
displayed anaberrant pattern of cytosine methylation of the maspin promoter. Morever the 
maspin promoter was observed to be methylated in maspin-negative normal peripheral blood 
lymphocytes. This indicated that the maspin promoter is not a functional CpG island and the 
cytosine methylation of this region may help in the contribution to normal tissue-restricted 
gene expression. Chromatin accessibility studies with MCF-7 cells, that lack maspin 
expression and have a methylated maspin promoter, was found to show a heterochromatin 
compared to that of HMECs. Maspin gene expression can also be activated in MCF-7 cells 
when treated with 5-aza-2-deoxycytidine, a DNA demethylating agent. Thus, aberrant 
cytosine methylation and formation of hetero chromatin structure of the maspin promoter 
may silence maspin gene expression, which contribute to the progression of human mammary 
cancer. Although the maspin expression is silenced, its deletions and mutations have not yet 
been found .These observations proved the hypothesis that the maspin might be suppressed 
by any epigenetic mechanism which involves aberrant cytosine methylation. In this study, it 
is reported that aberrant cytosine methylation of the maspin gene promoter in human breast 
cancer cell lines is associated with an altered chromatin configuration of the promoter and 
repression of maspin gene expression. In addition, it is shown that the methylation inhibitor 
5-aza-dC can re-activate maspin gene expression in a dose-dependent fashion in aberrantly 
methylated, maspin-negative breast cancer cells. (Domann E F et al, 2000) 
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3. OBJECTIVES  
The Objectives of our study are: 
1. To study the anti-proliferative effect of ethanolic and methanolic extract of tulsi 
leaves and inflorescence in MDA MB 231 breast cancer cells. 
2. Deciphering the anti-apoptotic potential of ethanolic and methanolic extract of tulsi 
leaves and inflorescence breast cancer cells. 
3. To study the anti-migratory effect of ethanolic and methanolic extract of tulsi leaves 
and inflorescence breast cancer cells. 
4. To investigate the role of ethanolic and methanolic extract of tulsi leaves and 
inflorescence on expression of tumor suppressor gene (Maspin), transcriptional factor 
(Snail), and epigenetic modulators (HDAC1 and HDAC2) with establishment of 
correlation between them. 
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4. MATERIALS AND METHODS: 
4.1. Preparation of Plant extract (EETL,METL,EETI): 
Tulsi (Ocimum sanctum) leaves and inflorescence were obtained from tulsi plants in 
NIT campus. The leaves and inflorescence were washed with distilled water and air dried. 
Then the extracts were prepared according to Othman et al, 2011. 60 g of leaves and 
inflorescence were ground using a grinder to obtain the fine powdered form, and the powder 
was kept in a flask with 120 ml of 80% ethanol added to it. The mixture was mixed and kept 
overnight at room temperature. The other day, the mixture was filtered into a beaker while 
the residue was left in the borosilicate glass bottle. Another 120 ml of 80% ethanol was then 
poured into the borosilicate glass bottle to soak the remaining residue, which was then kept 
overnight at room temperature. These steps were then repeated for the next three consecutive 
days. Ethanolic extract of tulsi leaves (EETL) and inflorescence (EETI) was evaporated using 
a rotary evaporator (RV 10 Basic IKA Rotary Evaporator) at 60˚C. Same procedure was 
repeated for methanolic extracts of tulsi leaves (METL) preparation, but in this case 60 gm of 
powdered leaves were extracted in 120 ml of absolute methanol and evaporated at 40˚C under 
vaccum.  After this the extracts were oven-dried for an additional 48 hours and then crude 
form stored at -20˚C. An aliquot of 200 mg of this dried extracts were dissolved in 500μL of 
dimethyl sulfoxide (DMSO) to prepare a stock of concentration 400 μg/μL. Secondary stock 
solutions of 40μg/μL were prepared by diluting the primary stock with ethanol and methanol 
for ethanolic and methanolic extract, respectively. The suspensions were then filtered with a 
0.22µm filter and stored at -20˚C. The final concentration of DMSO never exceeded 0.01% in 
the culture medium.  
4.2. Estimation of total phenol Content: 
Total phenolic content of the methanol and ethanolic extracts of Ocimum sanctum was 
determined by using Folin–Ciocalteu reagent and gallic acid (GA) as standard. To develop 
the standard curve, 0.5 mL aliquots of 12.5, 25, 50, 100, 200, and 400 μg/mL concentrations 
of methanolic gallic acid solutions were prepared from a stock of 400 mg/ml solution and 
EETL and METL were diluted to the concentration 200 µg/mL.  Then to each concentration 
of solution, 2.5 ml Folin’s reagent (diluted 1:9) and 2.5 ml (7.5g/100 mL) sodium carbonate 
were added. All determinations were performed in duplicate. The reaction mixture was 
incubated at 25
0
C for 30 min. Then phenolic contents were determined at 760 nm against 
reagent blank by UV Spectrophotometer (PerkinElmer). Total phenols were determined as 
gallic acid equivalents (GAE) (mg GAE/g extract) by the following formula:  
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C = c x V / m  
where C - total content of phenolic compounds, mg/g plant extract, in GAE 
          c - the concentration of gallic acid established from the calibration curve, mg/mL 
  V - the volume of extract, mL; 
  m - the weight of pure plant methanolic/ethanolic extract, g. 
4.3. Cell Line and Cell Culture: 
MDAMB 231 cell line was purchased from National Centre for Cell Science (NCCS),   
Pune, India. The cells are known to be of epithelial breast adenocarcinoma origin and are 
triple negative. These cells were maintained in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS) and 100 units/ml penicillin-
streptomycin sulfate (Invitrogen).  The cells were grown in 5% CO2 in humid condition at 
37
o
 C.  
4.4. Cell Viability Assay:  
This assay was done to determine the sub-lethal concentrations (IC50) of extracts and 
proliferative activity of the cells in presence of extracts. MDAMB 231 (80 % confluent) cells 
were seeded into 96 well plate at a density of 3×10
3 
cells/well. After 24 h, the cells were 
treated with tulsi extracts i.e ethanolic and methanolic extract of tulsi  leaves (EETL, METL), 
and ethanolic extract of tulsi inflorescence (EETI) at  7 different concentrations (10μg/mL, 25 
μg/mL, 50 μg/mL, 75 μg/mL, 100 μg/mL, 200 μg/mL, 400μg/ml ) and incubated for 24 h and 
48 h. In parallel the cells with the solvent control was also treated to assess its effect on cells. 
After completion of treatment duration, to detect the cell viability MTT working solution was 
prepared by diluting the stock solution (stock 5mg/ml PBS, PH 7.2) in growth medium 
without FBS to the final concentration of 0.8mg/ml. 100 μl of MTT working solution was 
added to each well and incubated for 4 hours in CO2 incubator. After incubation, the media 
was removed carefully without disturbing formazan precipitate and dissolved in 100 μl of 
100% DMSO. An incubation of 15 minutes was carried out in dark and the colorimetric 
estimation of formazan product was performed at 570nm in a microplate reader (Perkin 
Elmer). The experiment was repeated thrice and the data (mean ± S.D) were plotted against 
drug concentration and non- linear regression curve fitting was performed. 
4.5. Clonogenic Assay: 
MDA-MB-231 cells were plated at a low density (300 cells/well) in a 6 well plate, 
allowed to attach for 24 hours prior to treating with the extracts. Then cells were treated with 
METL, EETL, EETI at their respective IC50 values. Cells were grown until distinct colonies 
were visible in untreated controls. Then they were fixed and stained with a mixture of 6.0% 
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glutaraldehyde and 0.5% crystal violet, air dried, photographed and evaluated for colony 
estimation. 
4.6. Analysis of chromatin condensation by Hoechst 33342 stain: 
For chromatin condensation assay, MDA-MB-231 cells (10
4
cells/well) were seeded in 
6 well culture plates and allowed to grow for one day. Then cells were treated with METL, 
EETL, EETI at their respective IC50 values. After treatment with the extracts, the cells were 
stained with Hoechst 33342 stain (1 mg/ml) and incubated for 10 min at 37°C and images 
were taken under UV filter using Epi-fluorescent Microscope (Olympus IX71) at 400 X 
magnification. Condensed nucleus was counted against total number of nucleus in the field, 
and the percentages of apoptotic nuclei were analysed. 
4.7. Measurement of DNA Damage by Comet Assay: 
Comet assays were performed under alkaline conditions to determine the amount of 
double-strand DNA breaks. Two water baths were equilibrated at 40 °C and 100 °C 
respectively. Then 1% low-gelling-temperature agarose was prepared by mixing powdered 
agarose with distilled water in a glass bottle. The bottle was placed in the 100 °C water bath 
for several minutes and was transferred into a 40 °C water bath. Agarose-precoated slides 
were prepared by dipping the slides into molten 1% agarose and wiping one side clean. 
Agarose was allowed to air-dry to a thin film. Slides were prepared ahead of time and stored 
with desiccant.  
MDA-MB-231 were subjected to treatment with METL, EETL, EETI at their 
respective IC50 values for 24 h. Then cells were harvested and added to preheated (37°C) 
low-melting point agarose. The solution was pipetted onto slides precoated with 1% agarose. 
The slides were allowed to lyse overnight  at 4°C in alkaline lysis solution (1.2 M NaCl, 100 
mM Na2EDTA, 0.1% sodium lauryl sarcosinate, 0.26 M NaOH, pH > 13) prior to immersion 
in alkaline electrophoresis solution (0.03 M NaOH, 2 mM Na2EDTA, pH ∼12.3). After 30 
min, slides were placed into a horizontal electrophoresis chamber samples for 25 min (0.6 
V/cm). The slides were washed with deionized H2O to remove the alkaline buffer, stained 
with propidium iodide (10 μg/ml stock) and incubate for 20 min. The slides were then 
washed with water and examined by Epi-fluorescent Microscope (Olympus IX71).  
4.8. Cell migration assay (Scratch assay): 
MDA-MB-231 were seeded to 6 well plate to create a confluent monolayer and incubated 
properly for approximately 6 hours at 37°C, allowing cells to adhere and spread on the 
substrate completely. The required number of cells for a confluent monolayer depends on 
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both the particular cell type and the size of dishes and need to be adjusted appropriately. The 
cell monolayer was scraped in a straight line to create a scratch with a p200 pipet tip. 
The debris was removed and the edge of the scratch was smoothed by washing the cells 
once with 1 ml of 1X PBS, pH7.2 and then replaced with 2 ml of DMEM containing METL, 
EETL, EETI at their respective IC50 values. To obtain the same field during the image 
acquisition markings were created to be used as reference points close to the scratch. The first 
image of the scratch was taken and referred as 0 hour. After the wound in the control was 
healed up the photographs were taken under a phase-contrast microscope 
4.9. Total Cellular RNA isolation: 
The total cellular RNA was extracted using TRI reagent (Sigma), following the 
manufacturer's instructions. On the culture dish 1 ml of the TRI Reagent per 10 cm
2
 of glass 
culture plate surface area was added. After addition of the reagent, the cell lysate was passed 
several times through a pipette to form a homogenous lysate. TRI Reagent is not compatible 
with plastic culture plates. To ensure complete dissociation of nucleoprotein complexes, 
samples were allowed to stand for 5 minutes at room temperature. 0.1 ml of 1-bromo-3-
chloropropane or 0.2 ml of chloroform was added for per ml of TRI Reagent used. Samples 
were covered tightly, shaken vigorously for 15 seconds, and were allowed to stand for 2–15 
minutes at room temperature. The resulting mixture was centrifuged at 12,000 g for 15 
minutes at 2–8 °C. Centrifugation separates the mixture into 3 phases: a red organic phase 
(containing protein), an interphase (containing DNA), and a colorless upper aqueous phase 
(containing RNA).The aqueous phase was transferred to a fresh tube and 0.5 ml of 
isopropanol was added per ml of TRI Reagent used in Sample Preparation, step 1 and mixed. 
The sample was allowed to stand for 5–10 minutes at room temperature and centrifuged at 
12,000 g for 10 minutes at 2–8 °C. The RNA precipitate formed a pellet on the side and 
bottom of the tube. The supernatant was removed and RNA pellets were washed by adding a 
minimum of 1 ml of 75% ethanol per 1 ml of TRI Reagent used in Sample Preparation. The 
sample was vortexed and then centrifuged at 7,500 ´ g for 5 minutes at 2–8 °C. The RNA 
pellets were briefly dried for 5–10 minutes by air drying. An appropriate volume of nuclease 
free water was added and mixed by repeated tapping at 25 °C for 10–15 minutes. 
4.10. Estimation of total cellular RNA: 
Final preparation of RNA was analyzed using a nano-drop UV spectrophotometric 
analyzer. The standard preparation of RNA should have a 260/280 ratio of 1.8-2.0 and a 
260/230 ratio of <1.65 which indicates the preparation to be free from proteins and oligo-
peptides contamination. 
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4.11. cDNA Synthesis: 
In a 1.5 ml tube, 2 μg of template RNA was taken and the volume was adjusted to 11 μl 
with nuclease free water. To it 1 μl of oligo-dT primer was added to make a total volume of 
12 μl. The tube with the contents was mixed by centrifugation and incubated at 65°C for 5 
minutes. The tube was then snap cooled on ice and given a short spin. After that 4 μl of 
Reverse Transcriptase buffer (5X ) ,1 μl of Ribolock RI, 1 μl of Reverse Transcriptase, and 2 
μl of 10mM dNTP mix  was added to make a total volume of the reaction mixture 20 μl .The 
tube was then snap spinned for few minutes. The PCR was carried and the DNA was 
amplified under the following conditions- i.e. 42°C for 60 minutes and terminated at 70°C for 
5 minutes. The amplified cDNA was stored at -20°C for further processing. The synthesized 
cDNA was evaluated by performing PCR over one of the house keeping genes such as β-
actin. 
β-actin mRNA expression as internal control 
The amount of cDNA of different samples was so adjusted to have the expression of 
housekeeping gene (β-actin) similar in both control and treated samples. 
4.12. Gradient PCR:  
The PCR primers were chemically manufactured and procured from Sigma. A gradient 
PCR was done to optimize the annealing temperature of each set of primers. We used five 
sets of primers to amplify Maspin, Snail, HDAC-1, HDAC-2 and β-actin genes having 
sequence as detailed in Table no.1. The annealing temperature for each set of primers was 
optimized from 50˚C to 58˚C in order to obtain the most suitable temperature for the primers 
to be annealed on the target sequence. The PCR were carried out using standard protocols in 
a thermocycler (Bio-Rad) and the DNA was amplified under the following conditions: 95 °C 
for 5 min, 35 cycles of 95 °C for 30 s, 50˚C to 58˚C for 30 s, and 72 °C for 30 s, and the final 
extension of 72 °C for 5 min. The PCR products for each sample were electrophoresed on a 
1.5% agarose gel to determine the optimum annealing temperature.  
4.13. Gene Expression Analysis of Maspin, Snail, HDAC-1, HDAC-2 by Semi-
quantitative reverse-transcription PCR (Semi-q-RT-PCR): 
MDA-MB-231 cells were treated with sub lethal dosages of EETL, METL and EETL 
for 24 hours. Total cellular RNA was extracted from treated samples and untreated control 
with TriReagent (Sigma) according to the manufacturer’s instructions. cDNA was prepared 
using Thermo Scientific Revert Aid First Strand cDNA Synthesis Kit. cDNA from different 
treatment groups were used to analyze the expression of maspin, Snail, HDAC1 and HDAC2 
gene along with β-Actin as a house keeping gene. 
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PCR conditions: 
The PCR sample mixtures, in a 20 μl volume, contained 15.4μl of nuclease free water, 
2 μl of 10X PCR buffer (Thermo Scientific), 0.2 mM of dNTP (Thermo Scientific), 0.2 μM 
each of the forward and reverse primers of maspin, Snail, HDAC1, HDAC2, β-actin (Sigma) 
and 0.2 μl Taq DNA-polymerase (0.05U/μl, Pure gene) and optimized amount of each cDNA 
sample (in μl) was added. PCR amplifications of maspin, Snail, HDAC1, HDAC2, β-actin 
were performed in a thermal cycler by initial denaturation at 95 °C for 5 min, 35 cycles of 95 
°C for 30 s, 53˚C for 30 s, and 72 °C for 30 s, and the final extension of 72 °C for 5 min. 
4.14.  Agarose Gel Electrophoresis of the PCR products:  
The generated PCR products were analyzed by electrophoresis on 1.5% agarose gel. 
Agarose gel was prepared with 1X TAE (Tris Acetate EDTA, Sigma) buffer. Before casting 
1.5μl of ethidium bromide was added to the gel. 10 μl of sample (PCR product) was loaded to 
each well along with 2μl of 5 X loading dye. 1μl of ladder was loaded. The gel was run in 
TAE buffer at 80 volt for 35 minutes. 
4.15. Analysis of the Relative Expression level of Maspin and HDAC-1 by quantitative 
reverse-transcription PCR (q-RT-PCR): 
qRT-PCR was performed using SYBR® Green JumpStart™ TaqReadyMix in the 
Realplex4 Eppendorf system for maspin and HDAC1 gene. The mRNA level was normalized 
to β-Actin. The primer sequences for real time PCR are same as that of semi-q-RT-PCR and 
are given in Table 1.  
Table 1.Table showing the sequence of the forward and reverse primers 
SL.
NO. 
PRIMER 
NAME TYPE PRIMER SEQUENCE 
AMPLICON 
SIZE (in bp) 
1 
 
HDAC1 
Forward 5’-GGAAATCTATCGCCCTCACA-3’ 
168 
Reverse 5’-AACAGGCCATCGAATACTGG-3’ 
2 
 
HDAC2 
Forward           5’-ATAAAGCCACTGCCGAAGAA-3’ 
          245 
Reverse 5’-TCCTCCAGCCCAATTAACAG-3’ 
3 
 
MASPIN 
Forward 5’-GGAATGTCAGAGACCAAGGGA-3’ 
139 
Reverse 5’-GGTCAGCATTCAATTCATCCCTT-3’ 
4 
 
SNAIL 
Forward         5’-TCTAGGCCCTGGCTGCTACAA-3’ 
         131 
Reverse        5’-ACATCTGAGTGGGTCTGGAGGTG-3’ 
5 
 
β-ACTIN 
Forward 5’-TCTACAATGAGCTGCGTGTG-3’ 
250 
Reverse 5’-TCTCCTTCTGCATCCTGTC-3’ 
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5. RESULTS AND DISCUSSION 
5.1.1. Estimation of total phenolic content 
Total phenolic content of tulsi leaf extracts (EETL, METL and EETI) was determined 
using Folin-Ciocalteu assay (Khatoon et al., 2013). Samples comprising phenolic compounds 
are reduced by Folin-Ciocalteu reagent thereby generating a blue-coloured complex. The 
greater amount of phenolic complexes causes more potent free radical scavenging effects. 
Oxidation produces free radicals in food, drugs and often in living systems also (Pourmorad 
et al, 2006). These free radicals in turn cause various disorders in humans. Due to degradation 
of natural antioxidants in our immune system, consuming antioxidants that serve as free 
radical scavengers is indispensable. Antioxidant property of plants is most probably due to 
their phenolic compounds (Cook and Samman, 1996). Ocimum sanctum consists of 
flavonoids, a group of polyphenolic complexes associated with free radical scavenging 
activity. Phytochemicals with phenolic complexes have anticancer properties. Both mono and 
polyphenolic complexes in plant extracts suppress or inhibit the initiation, progression and 
invasion of cancers in cells in vitro (Wahle et al, 2010). Phenolic complexes can contribute to 
our body’s immune system by recognizing and destroying cancerous cells as well as 
suppressing angiogenesis required for tumor growth. They are also associated with 
attenuating adhesiveness, invasiveness and propagation of cancer cells thereby weakening 
their metastatic potential. The higher phenol content of EETL than METL and EETI indicates 
its higher anti-oxidant potential, which in turn can be correlated with its anti-cancer potential. 
The higher anti-cancer property of EETL has been further evaluated by investigating its anti-
proliferative, apoptotic and anti-migratory activity on MDA MB 231 breast cancer cells 
(Figure 3).  
 
 
 
 
 
Figure 3. Standard GA calibration curve and total phenolic content in EETL, METL and 
EETI. 
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5.1.2. Determination of  cytotoxic effect and IC50 value of EETL, METL and EETI by 
cell viability assay 
 
Cell viability of MDA MB -231 was determined after EETL, METL and EETI 
treatment by MTT Assay. The IC50 values for both the extracts were calculated. Treatment 
with EETL, METL and EETI showed decrease in cell viability but EETL treatment showed 
higher decrease in cell viability indicating more cytotoxicity towards breast cancer cells. The 
sub-lethal concentrations of different extracts (EETL, METL and EETI) were determined by 
MTT assay, which was taken as standardized concentration for further treatment. The 
optimized IC50 values of EETL, METL and EETI are 50 µg/ml, 75 µg/ml and 100 µg/ml for 
24 h in MDA-MB-231 cells (Figure 4). 
                          
                            
 
 
 
 
 
 
 
 
Figure 4. Graphical analysis of cell viability after EETL, METL and EETI treatment 
5.1.3. Detection of apoptosis induced by EETL, METL and EETI by Chromatin 
condensation assay 
The cell death inducing ability of neem leaf extracts is determined by chromatin 
condensation assay. This is indicated by formation of highly condensed and fragmented 
apoptotic bodies. Here, we found that the number of condensed nuclei in EETL treatment is 
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comparatively more than that of METL in MDA MB 231 breast cancer cells. The untreated 
controls show no condensed or fragmented nuclei (Figure 5).  
 
Figure 5. Fluorescence microscopic images representing condensed chromatin after EETL 
and METL treatment in MDA MB 231 breast cancer cells. 
5.1.4. Measurement of DNA damage induced by EETL, METL and EETI by Comet 
assay 
 
Comet assay denotes the extent of DNA damage due to apoptosis on application of 
any insults to the cells. The tail moment denotes the apoptosis inducing ability of extracts. 
The tail moment of comet in case of EETL treatment is higher than METL (Figure 6). The 
characteristic comet tail length suggested the amount of DNA damaged.  
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Figure 6. Fluorescence microscopic images of comets showing DNA damage after EETL, 
METL and EETI treatment. 
5.1.5. Determination of anti-migratory activity of EETL, METL and EETI on MDA 
MB 231 cells by Scratch assay  
To determine the migratory property of the MDA MB-231 cells after EETL, METL 
and EETI treatment for 24 h, the scratch assay was performed. While in control, the cancer 
cells migrate and close the gap in 24 h, in treatment groups very less number of cells migrate 
towards the gap. This indicates the anti-migratory property of tulsi extracts. Moreover, the 
wound healing ability of EETL is found to be least among all (Figure 7). The results showed 
that there was more migration of cells towards the scratched area in METL treated cells as 
compared to EETL treated cells in comparison with the untreated plates taken as control. This 
clearly demonstrates the efficient anti-migratory property of EETL on invasive breast cancer 
cells. 
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Figure 7. Microscopic images showing changes in the migratory property of MDA MB-231 
cells after EETL, METL and EETI treatment.  
5.1.6. Gene Expression Analysis of MASPIN, Snail, HDAC-1, HDAC-2 by Semi-
quantitative reverse-transcription PCR (Semi-q-RT-PCR) 
Semi-q-RT-PCR data confirmed that the transcript level of MASPIN is increased in 
MDA-MB 231 breast cancer cells after treatment with EETL and METL. MASPIN is a tumor 
suppressor gene, which has been reported to have low expression in breast cancer cells. Here 
in our study we also found the lower expression of MASPIN at transcription level. On 
treatment with EETL and METL, the MASPIN is demonstrated to be up-regulated in breast 
cancer cells (Figure 10). The EETL can more effectively restore the expression of MASPIN 
than METL, with higher expression of both HDAC1 and HDAC2 and lower expression of 
Snail (Figure 8). This denotes that EETL and METL may have HDAC inhibitory potential. 
The level of β-actin remains same in all cases. 
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Figure 8. Representative images of semi-q-RT-PCR result depicting expression level of 
MASPIN, Snail, HDAC-1, HDAC-2 and β-actin after EETL and METL treatment. 
5.1.7. Gene Expression Analysis of MASPIN and HDAC-1 by quantitative reverse-
transcription PCR (q-RT-PCR) 
The real time PCR analysis of mRNA levels of maspin and HDAC-1 shows that the 
maspin and HDAC-1 are up-regulated by 13 and 33 folds, respectively, in EETL than METL. 
This supports our finding from semi-q-RT-PCR study (Figure 9 and 10). The HDAC-1 is also 
demonstrated to be up-regulated in extract treated cancer cells (Figure 10). From the increase 
in transcript level of HDAC-1 in treatment groups, it is apparent that the EETL and METL 
have HDAC inhibitory activity. 
 
Figure 9. Graphical representation of RT-PCR results for expression level of HDAC1 after 
EETL, METL and EETI treatment 
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Figure 10. Graphical representation of RT-PCR results for expression level of MASPIN after    
EETL, METL and EETI treatment. 
6. CONCLUSION: 
It is very much clear from the current investigation that the tulsi leaf and inflorescence 
extracts have the anti-cancer potential. This anti-cancer potential is due to the combinatorial 
effect of anti-proliferative, apoptotic and anti-migratory effect of the tulsi extracts. It is 
demonstrated from our experiments that the EETL exert more anti-cancer effect on breast 
cancer cells than METL and EETI. This investigation also demonstrates the higher efficacy 
of EENL in restoring the expression of maspin with concurrent enhancement of HDAC-1 and 
HDAC-2 mRNA levels, and reduced expression of snail. This reflects the HDAC inhibitory 
activity of tulsi extract. Furher research in this regards will shed light on the HDAC 
inhibitory activity of tusi extracts, which can be used for the treatment of cancer. 
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